Assessment of response to therapy in advanced breast cancer: A project of the Programme on Clinical Oncology of the International Union against Cancer, Geneva, Switzerland

Assessment of response to therapy in adv

Assessment of response to therapy in advanced breast cancer: A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

✍ J.L. Hayward; R.D. Rubens; P.P. Carbone; J.-C. Heuson; S. Kumaoka; A. Segaloff 📂 Article 📅 1978 🏛 Elsevier Science ⚖ 103 KB

Assessment of response to therapy in adv

Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

✍ J. L. Hayward; P. P. Carbone; J-C Heuson; S. Kumaoka; A. Segaloff; R. D. Rubens 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 2 views

Patient's Anastrozole Compliance to Ther

Patient's Anastrozole Compliance to Therapy Programme (PACT) influence of the addition of a standardized information and reminder service on compliance in comparison to standard clinical care alone in women with early breast cancer

✍ P. Hadji; M. Blettner; R. Haidinger; N. Harbeck; C. Jackisch; H.J. Luck; R.R. Ma 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Impact of the Addition of Carboplatin an

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

✍ Sikov, William M. (author);Berry, Donald A. (author);Perou, Charles M. (author); 📂 Article 📅 2015 🏛 American Society of Clinical Oncology 🌐 English ⚖ 288 KB

Impact of the Addition of Carboplatin an

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

✍ Sikov, William M. (author);Berry, Donald A. (author);Perou, Charles M. (author); 📂 Article 📅 2015 🏛 American Society of Clinical Oncology 🌐 English ⚖ 288 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views